Author:
Victoria Kindt M.,Youngster Stephen K.,Sonsalla Patricia K.,Duvoisin Roger C.,Heikkila Richard E.
Reference27 articles.
1. (−)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease;Birkmayer;Mod. Probl. Pharmacopsychiat.,1983
2. Increased life expectancy resulting from addition of 1-deprenyl to Madopar treatment in Parkinson's disease: A longterm study;Birkmayer;J. Neural Transm.,1985
3. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;Burns,1983
4. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP);Burns;N. Engl. J. Med.,1985
5. Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;Chiba;Drug Metab. Disp.,1985
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献